Dynavax Technologies Corporation
Dynavax Technologies Corporation (DVAX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DVAX · as of Jun 8, 2026
Key Statistics
Explore Dynavax Technologies Corporation Data
dvax stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 81.8%
The DVAX analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $27.00, representing +74.19% upside from the current price of $15.50.
Competitors & Peers
dvax competitorsDVAX
AMPH
BBNX
COLL
ELVN
EVOStock Performance
Full HistoryAbout Dynavax Technologies Corporation
Dynavax Technologies Corporation a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for …
what is dynavax technologies corporation · dvax stock overview · dynavax technologies corporation company profile · who is dynavax technologies corporation ceo · dvax NASDAQ · dynavax technologies corporation headquarters · dynavax technologies corporation business segments
About Stock Overview & Key Data
Dynavax Technologies Corporation (DVAX) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Feb 19, 2004. As of the latest trading session, DVAX stock price is $15.50, with a market capitalization of $1.8B. The stock has returned +13.22% over the past 12 months and +0.78% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Dynavax Technologies Corporation stock is Buy, with an average 12-month price target of $27.00. In fiscal year 2024, Dynavax Technologies Corporation reported revenue of $277.2M and net income of $27.3M. For detailed data — including Dynavax Technologies Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Dynavax Technologies Corporation (DVAX) stock price is $15.50. The stock is traded on NASDAQ under the ticker symbol DVAX. The 52-week range is $9.20 – $15.73.